Navigation Links
Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
Date:8/1/2012

SAN DIEGO, Aug. 1, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Baxter's HyQ Biologics License Application (BLA). HyQ is an investigational product that includes plasma-derived Immune Globulin (IG) 10% and Halozyme's recombinant human hyaluronidase (rHuPH20) for subcutaneous administration in patients with primary immunodeficiency disease.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO )

The letter requested additional preclinical data to support the BLA. The primary issues raised in the letter focused on non-neutralizing antibodies generated against recombinant human hyaluronidase and the possible effects of these antibodies on reproduction, development and fertility. Elevated anti-rHuPH20 antibody titers were detected in the registration trial, but have not been associated with any adverse events.

Pending the parties providing additional preclinical data sufficient to address the regulatory questions, CBER has requested that patients should no longer be dosed with rHuPH20 in the Baxter and ViroPharma clinical studies.

Halozyme has been in contact with the Center for Drug Evaluation and Research (CDER) regarding the impact on Hylenex® recombinant (hyaluronidase human injection). CDER is the division of FDA regulating the other investigational rHuPH20 programs, including insulin and PEGPH20. After reviewing the data, CDER has confirmed that there is no need for actions against Hylenex or clinical programs in the Hylenex IND.

"With receipt of the CRL, we can directly address the questions raised by CBER," said Gregory I. Frost, Ph.D., President and Ch
'/>"/>

SOURCE Halozyme
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
2. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Halozyme Reports First Quarter 2012 Financial Results
4. Halozyme to Host First Quarter 2012 Financial Results Conference Call
5. Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement
6. Study Confirms Daniels Sharpsmart Helps Hospitals Reduce Carbon Footprint
7. Watson Confirms Testim® Patent Challenge
8. Watson Confirms Lo Loestrin® Fe Patent Challenge
9. Sirnaomics Received NIH SBIR Grant for Developing Its Scarless Wound Healing siRNA Therapeutics
10. Hologic Completes Acquisition Of Gen-Probe
11. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 ... market research report is available in its ... Market Forecast 2014-2024 ... Needle-free delivery – discover technological and commercial ... the needle-free delivery market? Visiongain,s brand new ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
(Date:8/28/2014)... 2014  Decision Resources Group finds that the market for ... billion by 2023 in the United States ... , Italy , Spain ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin ... by the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2
... , , , , , , SEATTLE, Dec. 28 Cell ... December 24, 2009, CTI,s Board of Directors (the "Board of Directors") ... which one preferred stock purchase right will be distributed for each ... 7, 2010. Initially, the rights are not exercisable, and are attached ...
... , , REDWOOD CITY, Calif., Dec. 24 ... focused on the development of improved versions of protein drugs, ... tender offer, which expired at 5:00 p.m., New York City ... the preliminary count by the depositary for the tender offer, ...
Cached Medicine Technology:Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 3Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 4Maxygen, Inc. Announces Preliminary Results of Dutch Auction Tender Offer 2
(Date:8/29/2014)... 29, 2014 After having a double ... had to have breast reconstruction. She found that the ... she decided that there needed to be a solution. ... a woman or man who needs or wants breast ... promotes confidence and peace of mind. Producible in design ...
(Date:8/29/2014)... 29, 2014 University of Western States ... professionals, announced that Daniel Redwood, DC, director of the ... of the Year,” by the Missouri State Chiropractors Association ... 21. , Patrick Montgomery, DC, president of the MSCA, ... the Missouri House Task Force for Medicaid Reform, in ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- The West African Ebola ... Health Organization announcing an estimated 500 new cases this week ... of the new cases arose in Liberia, the U.N. health ... rose sharply, the Associated Press reported. "There ... control," according to the WHO report. "The situation is worsening ...
(Date:8/29/2014)... August 29, 2014 Sansego ... videos, an interactive online community, and a range of ... beginners all the way to professional athletes. Crowie has ... have been with him throughout the majority of his ... everyone in the triathlon public. , Sansego provides the ...
(Date:8/29/2014)... ReputationChief.Com, a well-established online reputation management firm, has ... service has been launched to help individuals and organizations ... them. , In order to make sure that the ... to its clients, ReputationChief.Com has designed the service after ... , As per the indications from the company management, ...
Breaking Medicine News(10 mins):Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3Health News:ReputationChief.Com Announces a New Service ‘Remove Bad Reviews’ 2
... issue of the online journal Sexuality Research and ... reveal that abstinence-only-until-marriage sex education programs fail to change ... and violate human rights principles. Edited by John S. ... Department of Family and Population Health and Leslie M. ...
... Prestigious Award for Strong Market Share Growth, Product Innovation, ... ... Scottsdale, Ariz (PRWEB) September ... Management Solutions], Inc., a leading global security management company, ...
... holds that when it comes to aggression, boys hit ... exclude others, a type of aggression that,s called indirect, ... 150 studies of aggression in children and adolescents has ... likely to engage in physical aggression, girls and boys ...
... French . Montreal, September 16, 2008 ... than the birds and bees with their parents they ... out with older boys. A new study by researchers from ... Tufts University, published in the journal Child Development , ...
... flu? Not yet. But a new study offers new ... significant help. The three-year study showed that trial participants ... get a "Jackson" cold or flu. The very sensitive ... judging clinical symptoms, which include coughing, sneezing, runny noses ...
... AMDL, Inc. (Amex:,ADL), a vertically integrated pharmaceutical company with ... is reaffirming guidance for Q3 and,FY2008. Additionally, the Company ... to the heightened activity in its common stock,on the ... it is the Company,s normal policy to not comment ...
Cached Medicine News:Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 2Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 3Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 4Health News:Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award 2Health News:Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award 3Health News:Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award 4Health News:Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award 5Health News:Move over mean girls -- boys can be socially aggressive, too 2Health News:Troubled girls from poor neighborhoods more likely to have sex in early adolescence 2Health News:Troubled girls from poor neighborhoods more likely to have sex in early adolescence 3Health News:Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors 2Health News:Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors 3Health News:AMDL Reaffirms 2008 Guidance and Provides Additional Information 2Health News:AMDL Reaffirms 2008 Guidance and Provides Additional Information 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: